Followers | 17 |
Posts | 2713 |
Boards Moderated | 0 |
Alias Born | 04/30/2011 |
Wednesday, June 08, 2016 1:35:26 PM
"Methods and compositions to generate and control the effector profile of T cells by simultaneous loading and activation of selected subsets of antigen presenting cells" is an actual issued patent.
The rest are applications. Who knows if they will be issued.
If nobody is paying the fees to maintain them they will be abandoned.
And especially amusing in light of all the patents that MCET CLAIMED to have.
I never could figure out the Adrian Bot connection. He is now vice president at Kite Pharma, he doesn't ever list his potential affiliation with Multicell, if the patents were worth anything he wouldn't have left them behind.
HIs wife, Simona Bot was rescuing orphans in Romania before she was an advisor to "Multicell Techologies" whatever that was.
She likely never got paid much, she was never listed as a full time employee, though the Multicell Immunotherapies thing is just not very transparent. I think that the deal with Oxis was just a way to get Multicell the $500K they needed to pay the non-performance penalty for the stent.
Not sure why they would pay it though, there was nothing to protect, unless they though they could keep the scam going a little longer?
I do find it interesting that somebody is just not giving up.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM